Study of an investigational drug for diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes for at least 1 year, or you are a healthy volunteer.
- Your blood sugar control (HbA1c) must be within a certain range (6.5% to 9.5% for type 2 diabetes, 6% to 8.5% for type 1 diabetes).
- You use a long-acting insulin (like Lantus) daily for type 2 diabetes (in one part of the study).
- You have not had a serious low blood sugar episode or needed emergency care for high blood sugar in the last 6 months.
- You do not have any major heart, stomach, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.